Company Search:
Advanced Search
Sponsored Links
Alembic Ltd Company Snapshot
Alembic Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alembic Ltd with three other companies in this sector in India: Ambalal Sarabhai Enterprises Limited (2017 sales of 1.40 billion Indian Rupees [US$21.34 million] ), Jagsonpal Pharmaceuticals Limited (1.44 billion Indian Rupees [US$21.95 million] ), and Bharat Immunologicals & Biologicals Corporation Ltd (1.24 billion Indian Rupees [US$18.90 million] ).

Sales Analysis. Alembic Ltd reported sales of 1.37 billion Indian Rupees (US$20.91 million) for the fiscal year ending March of 2017. This represents an increase of 8.7% versus 2016, when the company's sales were 1.26 billion Indian Rupees. Despite this increase, sales are still below the level achieved in 2015, when Alembic Ltd reported sales of 1.46 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Alembic Ltd
  Stock Performance Chart for Alembic Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 56.40
(Figures in Indian Rupees)
1 Week -3.8%   13 Weeks 3.7%  
4 Weeks -11.1%   52 Weeks 15.8%  
Alembic Ltd Key Data:
  Ticker: ALEMBICLTD Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,373,868,000
(Year Ending Jan 2018).
Employees: 312
  Currency: Indian Rupees Market Cap: 15,060,595,099
  Fiscal Yr Ends: March Shares Outstanding: 267,031,828
  Share Type: Ordinary Closely Held Shares: 164,158,393
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.